Duquesne University Enters Largest Licensing Deal for Cancer
from Pittsburgh Business Times
Nearly 50 patents, developed quietly in the labs of Duquesne University, could hold big potential for the treatment of cancer. Working with Flag Therapeutics Inc., a Raleigh, N.C.-based startup run by Duquesne alum Frank Sorgi, the university has entered into a licensing agreement for two novel classes of duel-acting, water-soluble drugs developed for the treatment of cancer.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063